Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan · Delayed Price · Currency is TWD 24.55
-0.05 (-0.20%)
Jan 22, 2026, 11:50 AM CST
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.78 billion as of January 21, 2026. Its market cap has increased by 34.43% in one year.
Market Cap
1.78B
Enterprise Value
2.31B
Revenue
607.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.55
Market Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has increased from 1.58B to 1.78B, an increase of 12.72%. That is a compound annual growth rate of 0.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.78B | -4.28% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gwo Xi Stem Cell Applied Technology Co. , | 2.41B |
| TaiRx | 2.38B |
| TWi Biotechnology | 2.21B |
| Chunghwa Chemical Synthesis & Biotech | 2.00B |
| Great Novel Therapeutics Biotech & Medicals | 1.93B |
| NeoCore Technology | 1.58B |
| Advagene Biopharma | 1.56B |
| GenMont Biotech Incorporation | 1.55B |